HOSPITAL UNIVERSITARIO RUBER
Fachbereich
Baylor University Medical Center
Dallas, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Baylor University Medical Center (1)
2019
-
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: Cohort A of the phase II KEYNOTE-086 study
Annals of Oncology, Vol. 30, Núm. 3, pp. 397-404